Here you’ll find the most comprehensive and current information when it comes to the prevention and treatment of COVID-19.
COVID-19 prevention and treatments are constantly improving. Check here for the latest advances in prevention and disease management. Read about breaking research and news concerning vaccines, monoclonal antibodies, and other therapeutics with a focus on the immune compromised.
ADDITIONAL READING
In this interview, Dr. Brian Koffman spoke with Dr. Shmuel Shoham, a Professor of Clinical Medicine at Johns Hopkins University. Dr. Shoham specializes in the infectious disease care of immunocompromised patients, including those with leukemias and lymphomas. They discussed the use of convalescent plasma to treat COVID-19.
In the new COVID-19 guidelines released on August 11th, the US Centers for Disease Control and Prevention (CDC) made a change in their recommended infection control measures that are geared more towards increasing the focus on individuals understanding their own risk level for developing severe COVID-19 disease, making a personal decision
Don Diamond. Ph.D., has been working for decades at City of Hope, Duarte, CA, constructing a new vaccine platform that will benefit the immunocompromised. It’s already been successfully used in post allogeneic hematopoietic stem cell (bone marrow) transplants to prevent a different viral infection, CMV.
Dr. Leyfman discusses three medications that he hopes will prove to help with COVID-19
In our second interview, Dr. Leyfman shared his research on COVID-19 and cancer patients presented at the American Society of Clinical Oncology’s Annual Meeting or ASCO 2021. He discussed a radically different approach with an experimental cellular therapy, mesenchymal stem cells, which demonstrated a 91% overall survival and 100%
This abstract from the American Society of Hematology Annual Meeting and Exposition (ASH 2021) reported analysis of retrospective data from 91 adult patients in France with lymphoma or chronic lymphocytic leukemia (CLL) who enrolled in a study of antibody responses, measured two or more weeks after receiving second or
RECENT NEWS
When appropriate, the CLL Society will be posting updates and background information on the present Coronavirus pandemic focusing on reliable primary sources of information and avoiding most of the news that is not directly from reliable medical experts or government and world health agencies.
